EUR 300.27 For Business Accounts Only

Pharmaceuticals in Mexico

Summary

Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Mexican pharmaceuticals market had total revenues of $5,289.3m in 2019, representing a compound annual growth rate (CAGR) of 2.4% between 2015 and 2019.
- A growing middle class and better access to health care services are greatly increasing consumer demand for pharmaceutical products, including generics, in Mexico.
- Poor diets, most notably amongst the lower income population, and a shift to sedentary job roles and lifestyle habits will continue to drive growth in the Mexican market.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Mexico
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts

Reasons to Buy

- What was the size of the Mexico pharmaceuticals market by value in 2019?
- What will be the size of the Mexico pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Mexico pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Mexico's pharmaceuticals market?